KSR as a therapeutic target for Ras-dependent cancers

References

• Kornfeld K, Hom DB, Horvitz HR. The ksr-1 gene encodes a novel protein kinase involved in Ras-mediated signaling in C. elegans. Cell. 1995 Dec 15;83:903–913.
   PubMed Web of Science ®Google Scholar
• Sundaram M, Han M. The C. elegans ksr-1 gene encodes a novel Raf-related kinase involved in Ras-mediated signal transduction. Cell. 1995 Dec 15;83:889–901.
   PubMed Web of Science ®Google Scholar
• Therrien M, Chang HC, Solomon NM, et al. KSR, a novel protein kinase required for RAS signal transduction. Cell. 1995 Dec 15;83:879–888.
   PubMed Web of Science ®Google Scholar
• Downward J. KSR: a novel player in the RAS pathway. Cell. 1995 Dec 15;83:831–834.
   PubMed Web of Science ®Google Scholar
• Morrison DK. KSR: a MAPK scaffold of the Ras pathway? J Cell Sci. 2001 May;114:1609–1612.
   PubMed Web of Science ®Google Scholar
• Nguyen A, Burack WR, Stock JL, et al. Kinase suppressor of Ras (KSR) is a scaffold which facilitates mitogen-activated protein kinase activation in vivo. Mol Cell Biol. 2002 May;22:3035–3045.
   PubMed Web of Science ®Google Scholar
• Ritt DA, Daar IO, Morrison DK. KSR regulation of the Raf-MEK-ERK cascade. Methods Enzymol. 2006;407:224–237.
   PubMed Web of Science ®Google Scholar
• Brennan DF, Dar AC, Hertz NT, et al. A Raf-induced allosteric transition of KSR stimulates phosphorylation of MEK. Nature. 2011 Apr 21;472:366–369.
   PubMed Web of Science ®Google Scholar
• McKay MM, Freeman AK, Morrison DK. Complexity in KSR function revealed by Raf inhibitor and KSR structure studies. Small Gtpases. 2011 Sep;2:276–281.
   PubMedGoogle Scholar
• Kolch W. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nature reviews. Mol Cell Bio. 2005 Nov;6:827–837.
   Google Scholar
• Claperon A, Therrien M. KSR and CNK: two scaffolds regulating RAS-mediated RAF activation. Oncogene. 2007 May 14;26:3143–3158.
   PubMed Web of Science ®Google Scholar
• Raabe T, Rapp UR. KSR–a regulator and scaffold protein of the MAPK pathway. Sci STKE: Signal Trans Knowledge Environ. 2002 Jun 11;2002:pe28.
   PubMedGoogle Scholar
• Roy F, Laberge G, Douziech M, et al. KSR is a scaffold required for activation of the ERK/MAPK module. Genes Dev. 2002 Feb 15;16:427–438.
   PubMed Web of Science ®Google Scholar
• Kortum RL, Lewis RE. The molecular scaffold KSR1 regulates the proliferative and oncogenic potential of cells. Mol Cell Biol. 2004 May;24:4407–4416.
   PubMed Web of Science ®Google Scholar
• Kortum RL, Costanzo DL, Haferbier J, et al. The molecular scaffold kinase suppressor of Ras 1 (KSR1) regulates adipogenesis. Mol Cell Biol. 2005;25:7592–7604.
   PubMed Web of Science ®Google Scholar
• Liu L, Channavajhala PL, Rao VR, et al. Proteomic characterization of the dynamic KSR-2 interactome, a signaling scaffold complex in MAPK pathway. Biochim Biophys Acta. 2009;1794:1485–1495.
   PubMed Web of Science ®Google Scholar
• Huang L, Pan CQ, Li B, et al. Simulating EGFR-ERK signaling control by scaffold proteins KSR and MP1 reveals differential ligand-sensitivity co-regulated by Cbl-CIN85 and endophilin. Plos One. 2011;6:e22933.
   Google Scholar
• Kortum RL, Fernandez MR, Costanzo-Garvey DL, et al. Caveolin-1 is required for kinase suppressor of Ras 1 (KSR1)-mediated extracellular signal-regulated kinase 1/2 activation, H-RasV12-induced senescence, and transformation. Mol Cell Biol. 2014 Sep 15;34:3461–3472.
   PubMed Web of Science ®Google Scholar
• Karthik D, Majumder P, Palanisamy S, et al. Targeting cysteine rich C1 domain of Scaffold protein Kinase Suppressor of Ras (KSR) with anthocyanidins and flavonoids - a binding affinity characterization study. Bioinformation. 2014;10:580–585.
   PubMedGoogle Scholar
• Razidlo GL, Kortum RL, Haferbier JL, et al. Phosphorylation regulates KSR1 stability, ERK activation, and cell proliferation. J Biol Chem. 2004 Nov 12;279:47808–47814.
   PubMed Web of Science ®Google Scholar
• Razidlo GL, Johnson HJ, Stoeger SM, et al. KSR1 is required for cell cycle reinitiation following DNA damage. J Biol Chem. 2009 Mar 13;284:6705–6715.
   PubMed Web of Science ®Google Scholar
• Klutho PJ, Costanzo-Garvey DL, Lewis RE. Regulation of glucose homeostasis by KSR1 and MARK2. Plos One. 2011;6:e29304.
   Google Scholar
• Fisher KW, Das B, Kortum RL, et al. Kinase suppressor of ras 1 (KSR1) regulates PGC1alpha and estrogen-related receptor alpha to promote oncogenic Ras-dependent anchorage-independent growth. Mol Cell Biol. 2011;31:2453–2461.
   PubMed Web of Science ®Google Scholar
• McCall JL, Gehring D, Clymer BK, et al. KSR1 and EPHB4 regulate Myc and PGC1beta to promote survival of human colon tumors. Mol Cell Biol. 2016 Sep 1;36:2246–2261.
   PubMed Web of Science ®Google Scholar
• Fisher KW, Das B, Kim HS, et al. AMPK promotes aberrant PGC1beta expression to support human colon tumor cell survival. Mol Cell Biol. 2015 Nov;35:3866–3879.
   PubMed Web of Science ®Google Scholar
• Ohmachi M, Rocheleau CE, Church D, et al. C. elegans ksr-1 and ksr-2 have both unique and redundant functions and are required for MPK-1 ERK phosphorylation. Curr Bio: CB. 2002 Mar 5;12:427–433.
   PubMed Web of Science ®Google Scholar
• Hansen LA, Alexander N, Hogan ME, et al. Genetically null mice reveal a central role for epidermal growth factor receptor in the differentiation of the hair follicle and normal hair development. Am J Pathol. 1997;150:1959–1975.
   PubMed Web of Science ®Google Scholar
• Lozano J, Xing R, Cai Z, et al. Deficiency of kinase suppressor of Ras1 prevents oncogenic ras signaling in mice. Cancer Res. 2003 Jul 15;63:4232–4238.
   PubMed Web of Science ®Google Scholar
• Fusello AM, Mandik-Nayak L, Shih F, et al. The MAPK scaffold kinase suppressor of Ras is involved in ERK activation by stress and proinflammatory cytokines and induction of arthritis. J Immunology. 2006 Nov 01;177:6152–6158.
   PubMed Web of Science ®Google Scholar
• Le Borgne M, Filbert EL, Shaw AS. Kinase suppressor of Ras 1 is not required for the generation of regulatory and memory T cells. Plos One. 2013;8:e57137.
   Google Scholar
• Revelli JP, Smith D, Allen J, et al. Profound obesity secondary to hyperphagia in mice lacking kinase suppressor of ras 2. Obesity. 2011;19:1010–1018.
   PubMed Web of Science ®Google Scholar
• Henry MD, Costanzo-Garvey DL, Klutho PJ, et al. Obesity-dependent dysregulation of glucose homeostasis in kinase suppressor of ras 2-/- mice. Physiol Reports. 2014 Jul 1;2:e12053.
   Google Scholar
• Costanzo-Garvey DL, Pfluger PT, Dougherty MK, et al. KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity. Cell Metab. 2009;10:366–378.
   PubMed Web of Science ®Google Scholar
• Guo L, Costanzo-Garvey DL, Smith DR, et al. Cell non-autonomous regulation of hepatic IGF-1 and neonatal growth by Kinase Suppressor of Ras 2 (KSR2). Sci Rep. 2016 Aug 26;6:32093.
   PubMed Web of Science ®Google Scholar
• Fernandez MR, Henry MD, Lewis RE. Kinase suppressor of Ras 2 (KSR2) regulates tumor cell transformation via AMPK. Mol Cell Biol. 2012 Sep;32:3718–3731.
   PubMed Web of Science ®Google Scholar
• Dougherty MK, Ritt DA, Zhou M, et al. KSR2 is a calcineurin substrate that promotes ERK cascade activation in response to calcium signals. Mol Cell. 2009 Jun 26;34:652–662.
   PubMed Web of Science ®Google Scholar
• Dhawan NS, Scopton AP, Dar AC. Small molecule stabilization of the KSR inactive state antagonizes oncogenic Ras signalling. Nature. 2016 Aug 24;537:112–116.
   PubMed Web of Science ®Google Scholar
• Joneson T, Fulton JA, Volle DJ, et al. Kinase suppressor of Ras inhibits the activation of extracellular ligand-regulated (ERK) mitogen-activated protein (MAP) kinase by growth factors, activated Ras, and Ras effectors. J Biol Chem. 1998 Mar 27;273:7743–7748.
   PubMed Web of Science ®Google Scholar
• Kortum RL, Johnson HJ, Costanzo DL, et al. The molecular scaffold kinase suppressor of Ras 1 is a modifier of RasV12-induced and replicative senescence. Mol Cell Biol. 2006;26:2202–2214.
   PubMed Web of Science ®Google Scholar
• Stewart S, Sundaram M, Zhang Y, et al. Kinase suppressor of Ras forms a multiprotein signaling complex and modulates MEK localization. Mol Cell Biol. 1999 Aug;19:5523–5534.
   PubMed Web of Science ®Google Scholar
• McKay MM, Ritt DA, Morrison DK. Signaling dynamics of the KSR1 scaffold complex. Proc Natl Acad Sci U S A. 2009 Jul 7;106:11022–11027.
   PubMed Web of Science ®Google Scholar
• Udell CM, Rajakulendran T, Sicheri F, et al. Mechanistic principles of RAF kinase signaling. Cell Mol Life Sci: CMLS. 2011;68:553–565.
   PubMed Web of Science ®Google Scholar
• Koveal D, Schuh-Nuhfer N, Ritt D, et al. A CC-SAM, for coiled coil-sterile alpha motif, domain targets the scaffold KSR-1 to specific sites in the plasma membrane. Sci Signal. 2012 Dec 18;5:ra94.
   PubMed Web of Science ®Google Scholar
• Michaud NR, Therrien M, Cacace A, et al. KSR stimulates Raf-1 activity in a kinase-independent manner. Proc Natl Acad Sci U S A. 1997 Nov 25;94:12792–12796.
   PubMed Web of Science ®Google Scholar
• Zhou M, Horita DA, Waugh DS, et al. Solution structure and functional analysis of the cysteine-rich C1 domain of kinase suppressor of Ras (KSR). J Mol Biol. 2002 Jan 18;315:435–446.
   PubMed Web of Science ®Google Scholar
• Therrien M, Michaud NR, Rubin GM, et al. KSR modulates signal propagation within the MAPK cascade. Genes Dev. 1996 Nov 1;10:2684–2695.
   PubMed Web of Science ®Google Scholar
• Jacobs D, Glossip D, Xing H, et al. Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. Genes Dev. 1999 Jan 15;13:163–175.
   PubMed Web of Science ®Google Scholar
• Cacace AM, Michaud NR, Therrien M, et al. Identification of constitutive and ras-inducible phosphorylation sites of KSR: implications for 14-3-3 binding, mitogen-activated protein kinase binding, and KSR overexpression. Mol Cell Biol. 1999;19:229–240.
   PubMed Web of Science ®Google Scholar
• Muller J, Cacace AM, Lyons WE, et al. Identification of B-KSR1, a novel brain-specific isoform of KSR1 that functions in neuronal signaling. Mol Cell Biol. 2000;20:5529–5539.
   PubMed Web of Science ®Google Scholar
• Pearce LR, Atanassova N, Banton MC, et al. KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidation. Cell. 2013 Nov 7;155:765–777.
   PubMed Web of Science ®Google Scholar
• Guo L, Volle DJ, Lewis RE. Identification of a truncated kinase suppressor of Ras 2 mRNA in sperm. FEBS Open Bio. 2014;4:420–425.
   PubMed Web of Science ®Google Scholar
• Denouel-Galy A, Douville EM, Warne PH, et al. Murine Ksr interacts with MEK and inhibits Ras-induced transformation. Curr Bio: CB. 1998 Jan 1;8:46–55.
   PubMed Web of Science ®Google Scholar
• Sugimoto T, Stewart S, Han M, et al. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation. Embo J. 1998 Mar 16;17:1717–1727.
   PubMed Web of Science ®Google Scholar
• Yu W, Fantl WJ, Harrowe G, et al. Regulation of the MAP kinase pathway by mammalian Ksr through direct interaction with MEK and ERK. Curr Bio: CB. 1998 Jan 1;8:56–64.
   PubMed Web of Science ®Google Scholar
• Levchenko A, Bruck J, Sternberg PW. Scaffold proteins may biphasically affect the levels of mitogen-activated protein kinase signaling and reduce its threshold properties. Proc Natl Acad Sci U S A. 2000 May 23;97:5818–5823.
   PubMed Web of Science ®Google Scholar
• Morrison DK, Davis RJ. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu Rev Cell Dev Biol. 2003;19:91–118.
   PubMed Web of Science ®Google Scholar
• Matheny SA, Chen C, Kortum RL, et al. Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP. Nature. 2004 Jan 15;427:256–260.
   PubMed Web of Science ®Google Scholar
• Muller J, Ory S, Copeland T, et al. C-TAK1 regulates Ras signaling by phosphorylating the MAPK scaffold, KSR1. Mol Cell. 2001;8:983–993.
   PubMed Web of Science ®Google Scholar
• Ory S, Zhou M, Conrads TP, et al. Protein phosphatase 2A positively regulates Ras signaling by dephosphorylating KSR1 and Raf-1 on critical 14-3-3 binding sites. Curr Bio: CB. 2003 Aug 19;13:1356–1364.
   PubMed Web of Science ®Google Scholar
• Fantz DA, Jacobs D, Glossip D, et al. Docking sites on substrate proteins direct extracellular signal-regulated kinase to phosphorylate specific residues. J Biol Chem. 2001 Jul 20; 276 (29): 27256–65.
   Google Scholar
• Ritt DA, Zhou M, Conrads TP, et al. CK2 Is a component of the KSR1 scaffold complex that contributes to Raf kinase activation. Curr Biol. 2007 Jan 23;17(2):179–84.
   Google Scholar
• McKay MM and Morrison DK. Caspase-dependent cleavage disrupts the ERK cascade scaffolding function of KSR1. J Biol Chem. 2007 Sep 7; 282 (36): 26225–34.
   Google Scholar
• Rajakulendran T, Sahmi M, Lefrancois M, et al. A dimerization-dependent mechanism drives RAF catalytic activation. Nature. 2009 Sep 24;461:542–545.
   PubMed Web of Science ®Google Scholar
• Lavoie H, Therrien M. Regulation of RAF protein kinases in ERK signalling. Nature reviews. Mol Cell Bio. 2015 May;16:281–298.
   Google Scholar
• Casar B, Pinto A, Crespo P. ERK dimers and scaffold proteins: unexpected partners for a forgotten (cytoplasmic) task. Cell Cycle. 2009 Apr 01;8:1007–1013.
   PubMed Web of Science ®Google Scholar
• Casar B, Pinto A, Crespo P. Essential role of ERK dimers in the activation of cytoplasmic but not nuclear substrates by ERK-scaffold complexes. Mol Cell. 2008 Sep 05;31:708–721.
   PubMed Web of Science ®Google Scholar
• Lin WC, Iversen L, Tu HL, et al. H-Ras forms dimers on membrane surfaces via a protein-protein interface. Proc Natl Acad Sci U S A. 2014 Feb 25;111:2996–3001.
   PubMed Web of Science ®Google Scholar
• Nan X, Tamguney TM, Collisson EA, et al. Ras-GTP dimers activate the mitogen-activated protein kinase (MAPK) pathway. Proc Natl Acad Sci U S A. 2015 Jun 30;112:7996–8001.
   PubMed Web of Science ®Google Scholar
• Santos E. Dimerization opens new avenues into Ras signaling research. Sci Signal. 2014 May 06;7:pe12.
   PubMed Web of Science ®Google Scholar
• Kortum RL, Morrison DK. Path forward for RAF therapies: inhibition of monomers and dimers. Cancer Cell. 2015 Sep 14;28:279–281.
   PubMed Web of Science ®Google Scholar
• Gibney GT, Messina JL, Fedorenko IV, et al. Paradoxical oncogenesis–the long-term effects of BRAF inhibition in melanoma. Nature reviews. Clin Oncol. 2013;10:390–399.
   Web of Science ®Google Scholar
• Freeman AK, Ritt DA, Morrison DK. Effects of Raf dimerization and its inhibition on normal and disease-associated Raf signaling. Mol Cell. 2013 Feb 21;49:751–758.
   PubMed Web of Science ®Google Scholar
• Freeman AK, Ritt DA, Morrison DK. The importance of Raf dimerization in cell signaling. Small Gtpases. 2013;4:180-5 (Jul-Sep.
   PubMedGoogle Scholar
• Lavoie H, Thevakumaran N, Gavory G, et al. Inhibitors that stabilize a closed RAF kinase domain conformation induce dimerization. Nat Chem Biol. 2013;9:428–436.
   PubMed Web of Science ®Google Scholar
• Yao Z, Torres NM, Tao A, et al. BRAF mutants evade ERK-dependent feedback by different mechanisms that determine their sensitivity to pharmacologic inhibition. Cancer Cell. 2015 Sep 14;28:370–383.
   PubMed Web of Science ®Google Scholar
• Kholodenko BN. Drug resistance resulting from kinase dimerization is rationalized by thermodynamic factors describing allosteric inhibitor effects. Cell Rep. 2015 Sep 22;12:1939–1949.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yao B, Delikat S, et al. Kinase suppressor of Ras is ceramide-activated protein kinase. Cell. 1997 Apr 04;89:63–72.
   PubMed Web of Science ®Google Scholar
• Volle DJ, Fulton JA, Chaika OV, et al. Phosphorylation of the kinase suppressor of ras by associated kinases. Biochemistry. 1999 Apr 20;38:5130–5137.
   PubMed Web of Science ®Google Scholar
• Brennan JA, Volle DJ, Chaika OV, et al. Phosphorylation regulates the nucleocytoplasmic distribution of kinase suppressor of Ras. J Biol Chem. 2002 Feb 15;277:5369–5377.
   PubMed Web of Science ®Google Scholar
• Zhang J, Zafrullah M, Yang X, et al. Downregulation of KSR1 in pancreatic cancer xenografts by antisense oligonucleotide correlates with tumor drug uptake. Cancer Biol Ther. 2008;7:1490–1495.
   PubMed Web of Science ®Google Scholar
• Brown MD, Sacks DB. Protein scaffolds in MAP kinase signalling. Cell Signal. 2009 Apr;21:462–469.
   PubMed Web of Science ®Google Scholar